Author:
Xiao Li,Lu Zheng,Zhao Xuewei,Feng Yang,Zhao Ruixia,Qiu Zuchun,Chen Wei,Nie Guochao,Cao Huiling,Hou Yingchun
Reference51 articles.
1. Cancer statistics, 2022;R L Siegel;CA Cancer J Clin,2022
2. Cancer statistics;R L Siegel;CA Cancer J Clin,2019
3. Abplatin(IV) inhibited tumor growth on a patient derived cancer model of hepatocellular carcinoma and its comparative multi-omics study with cisplatin;X Li;J Nanobiotechnology,2022
4. The use of proteomic technologies to study molecular mechanisms of multidrug resistance in cancer;Y Cao;Eur J Med Chem,2019
5. Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: Preparation and antitumor activity of oximes, oxime ethers and a lactam;M V�gv�lgyi;Eur J Med Chem,2018